TY - JOUR
T1 - Blenderized food tube feeding in patients with head and neck cancer
AU - Spurlock, Amy L.
AU - Johnson, Teresa W.
AU - Pritchett, Ali
AU - Pierce, Leah
AU - Hussey, Jenna
AU - Johnson, Kelly
AU - Carter, Holly
AU - Davidson, Stephen L.
AU - Mundi, Manpreet S.
AU - Epp, Lisa
AU - Hurt, Ryan T.
N1 - Publisher Copyright:
© 2021 The Authors. Nutrition in Clinical Practice published by Wiley Periodicals LLC on behalf of American Society for Parenteral and Enteral Nutrition.
PY - 2022/6
Y1 - 2022/6
N2 - Background: Patients with headand neck cancer (HNC) are at high risk for malnutrition before and during chemoradiation treatment. Many will also require tube feeding to address declines in energy intake, weight, and quality of life (QOL) caused by the impact of treatment on gastrointestinal (GI) symptoms. Blenderized tube feeding (BTF) may ameliorate these adverse conditions. Methods: In this open-label, prospective pilot study, 30 patients with HNC who required feeding tube placement were recruited to switch from standard commercial formula after 2 weeks to a commercially prepared BTF formula. Weight, body mass index (BMI), GI symptoms, and QOL scores were tracked for 6 weeks from the first week of feeding tube placement. Results: Of the 16 patients who completed the 6-week assessment period, weights and BMI scores for 15 patients trended upward. For most patients, QOL and oral intake increased and GI symptoms decreased over the 6-week period, particularly during weeks 3 and 4, when the impact of treatment is particularly exacting on patients with HNC. Conclusion: BTF effectively mitigated weight loss, GI symptoms, QOL scores, and total energy intake in this group of patients with HNC who received tube feeding for 6 weeks.
AB - Background: Patients with headand neck cancer (HNC) are at high risk for malnutrition before and during chemoradiation treatment. Many will also require tube feeding to address declines in energy intake, weight, and quality of life (QOL) caused by the impact of treatment on gastrointestinal (GI) symptoms. Blenderized tube feeding (BTF) may ameliorate these adverse conditions. Methods: In this open-label, prospective pilot study, 30 patients with HNC who required feeding tube placement were recruited to switch from standard commercial formula after 2 weeks to a commercially prepared BTF formula. Weight, body mass index (BMI), GI symptoms, and QOL scores were tracked for 6 weeks from the first week of feeding tube placement. Results: Of the 16 patients who completed the 6-week assessment period, weights and BMI scores for 15 patients trended upward. For most patients, QOL and oral intake increased and GI symptoms decreased over the 6-week period, particularly during weeks 3 and 4, when the impact of treatment is particularly exacting on patients with HNC. Conclusion: BTF effectively mitigated weight loss, GI symptoms, QOL scores, and total energy intake in this group of patients with HNC who received tube feeding for 6 weeks.
KW - blenderized tube feeding
KW - enteral nutrition
KW - head and neck cancer
KW - malnutrition
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=85113859143&partnerID=8YFLogxK
U2 - 10.1002/ncp.10760
DO - 10.1002/ncp.10760
M3 - Article
C2 - 34462968
AN - SCOPUS:85113859143
SN - 0884-5336
VL - 37
SP - 615
EP - 624
JO - Nutrition in Clinical Practice
JF - Nutrition in Clinical Practice
IS - 3
ER -
